| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.37 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |